Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia

Andrea Szabó, Petra Hartmann, Renata Varga, Kristóf Jánvári, Zsanett Lendvai, Irén Szalai, Izabella Gomez, Gabriella Varga, Ferenc Greksa, István Németh, Zsolt Rázga, Margit Keresztes, Dénes Garab, M. Borós

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: Transient ischemia of osteoporotic bones during elective orthopedic surgery or fracture repair carries risks for serious complications, and estrogen loss or replacement has a potential to influence ischemia-reperfusion-induced inflammatory activation. To clarify this, we investigated the periosteal inflammatory changes in a clinically relevant time frame in ovariectomized rats, an experimental model of postmenopausal bone loss. Furthermore, the effects of chronic estrogen supplementation on the postischemic local and systemic inflammatory reactions were assessed. Main methods: Bilateral ovariectomy or sham operation was performed in 3-month-old female Sprague-Dawley rats. Five months later, estrogen replacement therapy with 17β-estradiol (20 μg- 1 kg- 1 day- 1) or vehicle treatment was initiated. The microcirculatory inflammatory consequences of 60-min total hindlimb ischemia followed by 180-min reperfusion were examined 11 months after ovariectomy and were compared with those in 3-month-old animals. Key findings: The osteoporosis that developed 5 months after ovariectomy was significantly ameliorated by estrogen replacement therapy. Both in ovariectomized and in non-ovariectomized animals, ischemia-reperfusion elevated the neutrophil adherence ∼ 3-fold in the postcapillary venules of the periosteum (intravital microscopy), with an ∼ 50-60% increase in intravascular neutrophil activation (CD11b; FACS analysis), an enhanced TNF-α release (ELISA) and periosteal expression of ICAM-1 (the endothelial ligand of CD11b; immunohistochemistry). Exogenous 17β-estradiol considerably reduced TNF-α release and the number of neutrophil-endothelial interactions in the periosteum, without affecting the CD11b and ICAM-1 expression changes. Significance: Osteoporosis itself does not increase the magnitude of the limb ischemia-reperfusion-associated periosteal inflammatory reaction. Chronic estrogen supplementation, however, reverses osteoporosis and significantly ameliorates the microcirculatory consequences of transient ischemia.

Original languageEnglish
Pages (from-to)156-162
Number of pages7
JournalLife Sciences
Volume88
Issue number3-4
DOIs
Publication statusPublished - 2011

Fingerprint

Tourniquets
Rats
Estrogens
Ischemia
Reperfusion
Ovariectomy
Osteoporosis
Intercellular Adhesion Molecule-1
Periosteum
Estrogen Replacement Therapy
Estradiol
Bone
Animals
Chemical activation
Neutrophils
Orthopedics
Neutrophil Activation
Postmenopausal Osteoporosis
Venules
Surgery

Keywords

  • Inflammation
  • Intravital microscopy
  • Ischemia-reperfusion
  • Neutrophil
  • Ovariectomy

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia. / Szabó, Andrea; Hartmann, Petra; Varga, Renata; Jánvári, Kristóf; Lendvai, Zsanett; Szalai, Irén; Gomez, Izabella; Varga, Gabriella; Greksa, Ferenc; Németh, István; Rázga, Zsolt; Keresztes, Margit; Garab, Dénes; Borós, M.

In: Life Sciences, Vol. 88, No. 3-4, 2011, p. 156-162.

Research output: Contribution to journalArticle

Szabó, A, Hartmann, P, Varga, R, Jánvári, K, Lendvai, Z, Szalai, I, Gomez, I, Varga, G, Greksa, F, Németh, I, Rázga, Z, Keresztes, M, Garab, D & Borós, M 2011, 'Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia', Life Sciences, vol. 88, no. 3-4, pp. 156-162. https://doi.org/10.1016/j.lfs.2010.11.004
Szabó, Andrea ; Hartmann, Petra ; Varga, Renata ; Jánvári, Kristóf ; Lendvai, Zsanett ; Szalai, Irén ; Gomez, Izabella ; Varga, Gabriella ; Greksa, Ferenc ; Németh, István ; Rázga, Zsolt ; Keresztes, Margit ; Garab, Dénes ; Borós, M. / Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia. In: Life Sciences. 2011 ; Vol. 88, No. 3-4. pp. 156-162.
@article{01e8b7bac2d64c9c8755672da0468157,
title = "Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia",
abstract = "Aims: Transient ischemia of osteoporotic bones during elective orthopedic surgery or fracture repair carries risks for serious complications, and estrogen loss or replacement has a potential to influence ischemia-reperfusion-induced inflammatory activation. To clarify this, we investigated the periosteal inflammatory changes in a clinically relevant time frame in ovariectomized rats, an experimental model of postmenopausal bone loss. Furthermore, the effects of chronic estrogen supplementation on the postischemic local and systemic inflammatory reactions were assessed. Main methods: Bilateral ovariectomy or sham operation was performed in 3-month-old female Sprague-Dawley rats. Five months later, estrogen replacement therapy with 17β-estradiol (20 μg- 1 kg- 1 day- 1) or vehicle treatment was initiated. The microcirculatory inflammatory consequences of 60-min total hindlimb ischemia followed by 180-min reperfusion were examined 11 months after ovariectomy and were compared with those in 3-month-old animals. Key findings: The osteoporosis that developed 5 months after ovariectomy was significantly ameliorated by estrogen replacement therapy. Both in ovariectomized and in non-ovariectomized animals, ischemia-reperfusion elevated the neutrophil adherence ∼ 3-fold in the postcapillary venules of the periosteum (intravital microscopy), with an ∼ 50-60{\%} increase in intravascular neutrophil activation (CD11b; FACS analysis), an enhanced TNF-α release (ELISA) and periosteal expression of ICAM-1 (the endothelial ligand of CD11b; immunohistochemistry). Exogenous 17β-estradiol considerably reduced TNF-α release and the number of neutrophil-endothelial interactions in the periosteum, without affecting the CD11b and ICAM-1 expression changes. Significance: Osteoporosis itself does not increase the magnitude of the limb ischemia-reperfusion-associated periosteal inflammatory reaction. Chronic estrogen supplementation, however, reverses osteoporosis and significantly ameliorates the microcirculatory consequences of transient ischemia.",
keywords = "Inflammation, Intravital microscopy, Ischemia-reperfusion, Neutrophil, Ovariectomy",
author = "Andrea Szab{\'o} and Petra Hartmann and Renata Varga and Krist{\'o}f J{\'a}nv{\'a}ri and Zsanett Lendvai and Ir{\'e}n Szalai and Izabella Gomez and Gabriella Varga and Ferenc Greksa and Istv{\'a}n N{\'e}meth and Zsolt R{\'a}zga and Margit Keresztes and D{\'e}nes Garab and M. Bor{\'o}s",
year = "2011",
doi = "10.1016/j.lfs.2010.11.004",
language = "English",
volume = "88",
pages = "156--162",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "3-4",

}

TY - JOUR

T1 - Periosteal microcirculatory action of chronic estrogen supplementation in osteoporotic rats challenged with tourniquet ischemia

AU - Szabó, Andrea

AU - Hartmann, Petra

AU - Varga, Renata

AU - Jánvári, Kristóf

AU - Lendvai, Zsanett

AU - Szalai, Irén

AU - Gomez, Izabella

AU - Varga, Gabriella

AU - Greksa, Ferenc

AU - Németh, István

AU - Rázga, Zsolt

AU - Keresztes, Margit

AU - Garab, Dénes

AU - Borós, M.

PY - 2011

Y1 - 2011

N2 - Aims: Transient ischemia of osteoporotic bones during elective orthopedic surgery or fracture repair carries risks for serious complications, and estrogen loss or replacement has a potential to influence ischemia-reperfusion-induced inflammatory activation. To clarify this, we investigated the periosteal inflammatory changes in a clinically relevant time frame in ovariectomized rats, an experimental model of postmenopausal bone loss. Furthermore, the effects of chronic estrogen supplementation on the postischemic local and systemic inflammatory reactions were assessed. Main methods: Bilateral ovariectomy or sham operation was performed in 3-month-old female Sprague-Dawley rats. Five months later, estrogen replacement therapy with 17β-estradiol (20 μg- 1 kg- 1 day- 1) or vehicle treatment was initiated. The microcirculatory inflammatory consequences of 60-min total hindlimb ischemia followed by 180-min reperfusion were examined 11 months after ovariectomy and were compared with those in 3-month-old animals. Key findings: The osteoporosis that developed 5 months after ovariectomy was significantly ameliorated by estrogen replacement therapy. Both in ovariectomized and in non-ovariectomized animals, ischemia-reperfusion elevated the neutrophil adherence ∼ 3-fold in the postcapillary venules of the periosteum (intravital microscopy), with an ∼ 50-60% increase in intravascular neutrophil activation (CD11b; FACS analysis), an enhanced TNF-α release (ELISA) and periosteal expression of ICAM-1 (the endothelial ligand of CD11b; immunohistochemistry). Exogenous 17β-estradiol considerably reduced TNF-α release and the number of neutrophil-endothelial interactions in the periosteum, without affecting the CD11b and ICAM-1 expression changes. Significance: Osteoporosis itself does not increase the magnitude of the limb ischemia-reperfusion-associated periosteal inflammatory reaction. Chronic estrogen supplementation, however, reverses osteoporosis and significantly ameliorates the microcirculatory consequences of transient ischemia.

AB - Aims: Transient ischemia of osteoporotic bones during elective orthopedic surgery or fracture repair carries risks for serious complications, and estrogen loss or replacement has a potential to influence ischemia-reperfusion-induced inflammatory activation. To clarify this, we investigated the periosteal inflammatory changes in a clinically relevant time frame in ovariectomized rats, an experimental model of postmenopausal bone loss. Furthermore, the effects of chronic estrogen supplementation on the postischemic local and systemic inflammatory reactions were assessed. Main methods: Bilateral ovariectomy or sham operation was performed in 3-month-old female Sprague-Dawley rats. Five months later, estrogen replacement therapy with 17β-estradiol (20 μg- 1 kg- 1 day- 1) or vehicle treatment was initiated. The microcirculatory inflammatory consequences of 60-min total hindlimb ischemia followed by 180-min reperfusion were examined 11 months after ovariectomy and were compared with those in 3-month-old animals. Key findings: The osteoporosis that developed 5 months after ovariectomy was significantly ameliorated by estrogen replacement therapy. Both in ovariectomized and in non-ovariectomized animals, ischemia-reperfusion elevated the neutrophil adherence ∼ 3-fold in the postcapillary venules of the periosteum (intravital microscopy), with an ∼ 50-60% increase in intravascular neutrophil activation (CD11b; FACS analysis), an enhanced TNF-α release (ELISA) and periosteal expression of ICAM-1 (the endothelial ligand of CD11b; immunohistochemistry). Exogenous 17β-estradiol considerably reduced TNF-α release and the number of neutrophil-endothelial interactions in the periosteum, without affecting the CD11b and ICAM-1 expression changes. Significance: Osteoporosis itself does not increase the magnitude of the limb ischemia-reperfusion-associated periosteal inflammatory reaction. Chronic estrogen supplementation, however, reverses osteoporosis and significantly ameliorates the microcirculatory consequences of transient ischemia.

KW - Inflammation

KW - Intravital microscopy

KW - Ischemia-reperfusion

KW - Neutrophil

KW - Ovariectomy

UR - http://www.scopus.com/inward/record.url?scp=79251646602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251646602&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2010.11.004

DO - 10.1016/j.lfs.2010.11.004

M3 - Article

VL - 88

SP - 156

EP - 162

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 3-4

ER -